Browse Articles
Discover research articles across all indexed journals
Dysregulation of miRNA expression and 3′UTR length variation in target mRNAs in the testes of dogs with cryptorchidism
The relationships between the physical fitness levels of geriatric individuals and their static and dynamic balance
Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma
Explainable detection of goldenhar syndrome using an OD-Mamba backbone for rare craniofacial disorder diagnosis
Age-related odor and design buffering in elderly solo housing: two-stage study of visitor behavioral intention
Evaluating hydrogel efficacy on biomass and survival of Casuarina equisetifolia L. and Grevillea robusta A. Cunn. ex R. Br. seedlings
Incorporation of Novel Synthetic Glycolipids in Liposomal Nanoparticles Affects Opsonization and In Vivo Clearance
ABSTRACT Mimicking cell membrane glycocalyx, saccharide modification of nanoparticles offers a potent means to regulate their in vivo fate. Here, we investigate how glycosylation (i.e., glucose, galactose, fructose, mannose, and N ‐acetylglucosamine) regulates liposomal nanoparticle interactions with plasma proteins and immune cells, which further determine their biodistribution and therapeutic efficacy. While fructose conferred the greatest enhancement in tumor cell uptake in vitro, N ‐acetylglucosamine‐modified nanoparticles achieved the highest tumor accumulation and markedly attenuated systemic clearance in vivo, highlighting a pronounced disparity between in vitro and in vivo performance. The compromised in vivo efficacy of glycosylated nanoparticles was linked to significant clearance in blood, liver, and spleen, primarily mediated by blood monocytes, hepatic stellate cells, and splenic macrophages. Proteomics revealed that adsorption of immunoglobulin G (IgG) and complement C3 facilitates in vivo clearance of nanoparticles. Moreover, IgG deposition further promotes subsequent C3 binding. Notably, N ‐acetylglucosamine markedly mitigates IgG and C3 adsorption, leading to prolonged circulation and enhanced tumor accumulation and inhibition. Benefiting from glycosylation‐regulated protein corona, doxorubicin‐loaded N ‐acetylglucosamine‐modified liposomal nanoparticles achieved superior antitumor efficacy compared with other glycosylated formulations. This study establishes a clear correlation between glycosyl ligand identity, protein corona composition, and in vivo performance, providing fundamental insights for rational design and clinical translation of glycosylated nanomedicines.
Retraction Note: Prediction of DDoS attacks in agriculture 4.0 with the help of prairie dog optimization algorithm with IDSNet
BIS-guided light versus deep general anesthesia on postoperative cognitive dysfunction in older patients with regional nerve block: a randomised controlled trial
Abstract Postoperative cognitive dysfunction (POCD) is a common and serious complication in older surgical patients. The impact of anesthetic depth on cognitive recovery, particularly when combined with regional analgesia, requires further elucidation. In this single-center, prospective, randomized, assessor-blinded trial, A total of 100 Older Patients (≥ 60 years) scheduled for elective lower limb orthopedic surgery were enrolled. All patients received an ultrasound-guided iliofascial block. They were then randomly assigned to receive either Bispectral index(BIS) guided light anesthesia (BIS 50–60, n = 50) or deep anesthesia (BIS < 45, n = 50)[1]. The primary outcome was the trajectory of cognitive function assessed by the Montreal Cognitive Assessment (MoCA) score preoperatively and on postoperative days 1, 3, and 7. Secondary outcomes included the incidence of POCD, postoperative nausea and vomiting (PONV), intraoperative burst suppression, and hospital length of stay. Compared with the deep anesthesia group, the light anesthesia group was associated with significantly better postoperative cognitive function. MoCA scores were higher in the light anesthesia group at all postoperative time points (all p < 0.01). The incidence of POCD on postoperative day 1 was markedly lower in the light anesthesia group (14.0% vs. 42.0%; p = 0.002). Patients receiving light anesthesia also had a lower incidence of PONV (16.0% vs. 40.0%; p = 0.008), a lower incidence of intraoperative burst suppression (20.0% vs. 48.0%; p = 0.003), and a significantly shorter median hospital stay (7.0 vs. 9.5 days; p = 0.01). In Older Patients undergoing lower limb surgery with regional nerve blockade, a BIS-guided light anesthesia strategy, compared with a deep anesthesia strategy, resulted in better early postoperative cognitive recovery, a lower risk of POCD, and improved quality of recovery, characterised by fewer complications and a shorter hospital stay.
Correction: EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells
Association of anti-catecholaminergic antiarrhythmic drugs with survival in sepsis-associated new-onset atrial fibrillation
Abstract Sepsis-induced new-onset atrial fibrillation (NOAF) is a potentially life-threatening arrhythmogenic complication, partially driven by catecholamine-mediated atrial remodeling. While β-adrenergic receptor blockers may mitigate this pathophysiology through sympatholytic and rate-controlling mechanisms, their association with patient survival remains incompletely characterized due to heterogeneous evidence. To elucidate the association between the administration of anti-catecholaminergic antiarrhythmic drugs and all-cause mortality in critically ill patients with sepsis-induced NOAF.This retrospective cohort study utilized data from the Medical Information Mart for Intensive Care-IV database. We included adult patients admitted to a tertiary academic medical center between 2008 and 2019 who fulfilled the Sepsis-3 criteria and developed NOAF during their ICU stays.Based on the initial antiarrhythmic drug administration within 24 h following time-zero, patients were categorized into either β-blocker group or alternative antiarrhythmic drug group. The matched cohort comprised 560 patients (mean age 74.1 [SD 11.5] years; 64.6% male), among whom 280 were assigned to the β-blocker group and 280 to the alternative antiarrhythmic drug group. The β-blocker group demonstrated significantly lower 28-day mortality (36.1 vs. 51.1%; adjusted HR, 0.53; 95% CI, 0.41–0.67; P < .001) and 1-year mortality (50.7 vs. 63.6%; adjusted HR, 0.68; 95% CI, 0.55–0.85; P = .001). ICU mortality was also reduced in the β-blocker group (22.1 vs. 42.5%; P < .001). Furthermore, this group had more vasopressor-free days (median [IQR], 24.0 [18.0–26.0] vs. 16.0 [0.0–23.0]) and ventilator-free days (24.0 [18.0–26.0] vs. 17.0 [0.0–24.0]) (both P < .001). Safety outcomes included less bradycardia (12.5 vs. 20.0%; P = .016) but more hypotension (26.4 vs. 18.6%; P = .039). Subgroup and mediation analyses suggested greater benefit in high-risk patients, partially mediated (15.92%) by reduced vasopressor requirements. In critically ill patients with sepsis-induced NOAF, early β-blocker therapy was associated with markedly lower 28-day and 1-year mortality, along with decreased organ-support burden, warranting prospective trials are warranted to confirm these survival benefits.
Multispecies transboundary landscape connectivity in the KAZA TFCA
Abstract This study aimed to delineate multi-species corridors across the KAZA landscape to be included in land use planning and identify which wildlife dispersal areas (WDA) are most critical for seven key mammal species across KAZA. For each species, we modelled habitat suitability across KAZA using ~ 48,000 occurrence points, from both camera trap and spoor surveys. Data from different sources were individually analysed, combined in an ensemble model and final outputs overlayed to form a multi-species layer, with which we assessed connectivity identifying core areas (KDE), corridors (LCP) and functional habitat in KAZA. The central KAZA region, from the Okavango Delta and Chobe National Park to Hwange National Park, supports the most extensive, well-connected core habitat for multiple species. Connectivity weakens toward the Sebungwe region, Angola, Namibia, and Kafue due to major rivers, veterinary fences, and growing human settlement/development. However, substantial highly suitable habitat occurs outside protected areas, with some WDAs playing disproportionately important roles in sustaining species’ connectivity. No single species serves as an umbrella for others when identifying critical corridors, making multi-species analyses essential for comprehensive conservation planning. Protecting corridors and core areas across KAZA depends largely on land uses outside protected areas, underscoring the need to integrate multi-species corridors into land-use planning and to promote coexistence between people and wildlife.
Investigation on absorption refrigeration performance of R1243zf with imidazolium ionic liquid as the working pairs
A Highly Strained All‐BODIPY‐Based Nanohoop
ABSTRACT Highly strained π‐conjugated nanohoops present significant synthetic challenges but offer interesting platforms for exploring unique physical properties. Here, we report the synthesis of β‐β directly connected strained cyclic boron‐dipyrromethene (BODIPY) tetramer— [4]CBDP , with its structure unambiguously confirmed by single‐crystal X‐ray diffraction. Importantly, the radially conjugated architecture narrows the HOMO‐LUMO gap, yielding panchromatic absorption spanning the visible spectrum with an edge extending into the NIR‐I window, and resulting in a large Stokes shift (77 nm). Computational results indicate that [4]CBDP exhibits a high strain energy of 155 kcal/mol; yet it remains stable under ambient conditions (air/light) in both solution and the solid state.
Advancing low-carbon additive manufacturing: an integrated deep learning approach for optimal resource and capacity management
Comparison of DeepSeek-V3.2 and ChatGPT-5.2 in the outpatient diagnosis and treatment of prostate cancer: a multicenter evaluation of application value and multilingual adaptability
Enantioselective Total Syntheses of Bisleuconothine A and Bousigonine B
ABSTRACT Hetero‐oligomeric monoterpenoid indole alkaloids (MIAs), which possess unique three‐dimensional architectures and relatively high molecular weights, are intriguing targets in drug discovery owing to their potential to disrupt protein–protein interactions. Herein, we describe the first enantioselective total syntheses of bisleuconothine A, a dimeric MIA, and bousigonine B, a trimeric MIA. The central element of our strategy is the concise construction of a chiral 3‐ethylpiperidine scaffold, a common structural motif in MIAs. This key intermediate was prepared using a cascade sequence comprising an organocatalytic enantioselective Michael addition of a cyclic enamine to acrolein promoted by a chiral secondary amine catalyst, followed by hemiaminal cyclization and acetalization. Coupling of the aspidosperma‐ and eburnane‐type fragments, both derived from this common intermediate, was accomplished via a biomimetic Friedel–Crafts‐type reaction. The present total synthesis also revises the absolute stereochemistry of bousigonine B and constitutes the first total synthesis of a trimeric MIA.
Simulation of multi-mechanism deposition characteristics of dust particles on the cylindrical surface based on lattice Boltzmann method
Community-aware sparse topology design for efficient spiking neural networks
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma
Abstract Children and adolescents with classical Hodgkin lymphoma have a progression-free survival (PFS) rate of ≥ 90% with current treatments. The current challenge is to reduce adverse late-effects while maintaining high survival. Distinguishing lung involvement (Stage IV) from benign lung lesions remains a staging challenge in pediatric Hodgkin lymphoma (pHL). This study analyzed the prevalence, morphological patterns, and prognostic impact of lung lesions on progression-free survival (PFS) within the EuroNet-PHL-C1 trial. A retrospective analysis was conducted on chest CT scans from 1,298 pHL patients enrolled in the EuroNet-PHL-C1 trial. Patients were stratified by established treatment groups (TG-1, TG-2, TG-3). Lesions were classified by morphological pattern, and Kaplan-Meier analysis was used to compare 60-month PFS between groups with and without lung lesions. Lung lesions were identified in 60.2% (782/1298) of patients, with nodules being the predominant pattern (89%). In the combined TG-1 and TG-2 cohort (early/intermediate stages), the presence of any lung lesion correlated with significantly lower 5-year PFS (85.5% vs. 91.7%; p = 0.0197). Importantly, this lower PFS was driven by non-nodule morphologies. In the TG-3 (advanced stage) cohort, neither the presence of lung lesions nor stage IV classification significantly affected PFS. Lung lesions are highly prevalent in pHL. However, the presence of pulmonary nodules does not confer an inferior prognosis. The prognostic impact of lung lesions is primarily limited to non-nodule patterns in early-stage disease. These findings suggest that incorporating morphological patterns may be beneficial for refining risk stratification in future pHL trials.